← Back to CLDX

Celldex Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 06/08/2026Sep 2025Filed 10/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 06/08/2026Sep 2024Filed 10/11/2025Jun 2024Filed 10/11/2025Mar 2024Filed 10/11/2025
$0$0$0.7$0.7$3.2$2.5$0.2
−$74−$79−$67−$57−$54−$42−$36−$33
−$0.94−$1.18−$1.01−$0.85−$0.81−$0.64−$0.54−$0.56
78676666

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.